NMAVX
Price
$12.12
Change
-$0.04 (-0.33%)
Updated
Jul 18 closing price
Net Assets
503.93M
VMVIX
Price
$65.84
Change
+$0.17 (+0.26%)
Updated
Jul 18 closing price
Net Assets
30.57B
Interact to see
Advertisement

NMAVX vs VMVIX

Header iconNMAVX vs VMVIX Comparison
Open Charts NMAVX vs VMVIXBanner chart's image
Nuance Mid Cap Value Investor
Price$12.12
Change-$0.04 (-0.33%)
VolumeN/A
Net Assets503.93M
Vanguard Mid-Cap Value Index Investor
Price$65.84
Change+$0.17 (+0.26%)
VolumeN/A
Net Assets30.57B
NMAVX vs VMVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NMAVX vs. VMVIX commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMAVX is a Buy and VMVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 30.6B vs. NMAVX (504M). NMAVX pays higher dividends than VMVIX: NMAVX (2.39) vs VMVIX (2.14). NMAVX was incepted earlier than VMVIX: NMAVX (12 years) vs VMVIX (19 years). NMAVX (1.24) is less costly to investors than VMVIX (0.19). NMAVX is a more actively managed with annual turnover of: 74.00 vs. VMVIX (19.00). NMAVX has a lower initial minimum investment than VMVIX: NMAVX (2500) vs VMVIX (3000). VMVIX annual gain was more profitable for investors over the last year : 5.78 vs. NMAVX (-2.28). VMVIX return over 5 years is better than : 68.95 vs. NMAVX (3.45).
NMAVXVMVIXNMAVX / VMVIX
Total Expense Ratio1.190.19626%
Annual Report Gross Expense Ratio1.240.19653%
Fund Existence12 years19 years-
Gain YTD0.5833.18118%
Front Load5%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets504M30.6B2%
Annual Yield % from dividends2.392.14112%
Returns for 1 year-2.285.78-39%
Returns for 3 years0.7028.932%
Returns for 5 years3.4568.955%
Returns for 10 years28.9987.1733%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DDS461.6720.56
+4.66%
Dillards
JANX27.750.75
+2.78%
Janux Therapeutics
SKYH10.360.23
+2.27%
Sky Harbour Group Corporation
CLST12.280.01
+0.08%
Catalyst Bancorp
TDACU10.43N/A
N/A
Translational Development Acquisition Corp